A provider of laser solutions for stem cell research and fertility markets, Hamilton Thorne has unveiled the LYKOS laser solution for the fertility and clinical markets. The company will introduce the laser systems at the European Society of Human Reproduction and Embryology that will take place in Sweden from July 3 to July 6, 2011.
The laser system provides enhanced compatibility and resolution, enhanced optics, and additional functionality with key microscope models. The device has directly built the RED-i target locator and the laser inside the objective, thereby enabling researchers to abstain from tedious alignment procedure. It has an enhanced working distance that offers substantial benefit in everyday workflow.
The laser solution also incorporates improved UV fluorescence and transmission and provides additional advantages for clinical processes such as laser-assisted hatching, pre-implantation genetic diagnosis, blastomere biopsy, and trophectoderm biopsy.
Hamilton’s CEO, Meg Spencer stated that the enhanced resolution and image quality offers immediate advantages for customers in the IVF clinics. The laser solution enables researchers to carry out sophisticated cellular research that paves the way for enhanced scientific processes. Spencer added that laser technology is being used by researchers to unmask therapeutic treatments for various diseases.